Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights Read more about Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Agios Reports Business Highlights and Third Quarter 2023 Financial Results Read more about Agios Reports Business Highlights and Third Quarter 2023 Financial Results
Agios Reports Business Highlights and Second Quarter 2023 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2023 Financial Results
Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response Read more about Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response
Agios Reports Business Highlights and First Quarter 2023 Financial Results Read more about Agios Reports Business Highlights and First Quarter 2023 Financial Results
Agios Reports Fourth Quarter and Full Year 2022 Financial Results Read more about Agios Reports Fourth Quarter and Full Year 2022 Financial Results
Agios Reports Business Highlights and Third Quarter 2022 Financial Results Read more about Agios Reports Business Highlights and Third Quarter 2022 Financial Results
Agios Reports Business Highlights and Second Quarter 2022 Financial Results Read more about Agios Reports Business Highlights and Second Quarter 2022 Financial Results
Agios Reports Business Highlights and First Quarter 2022 Financial Results Read more about Agios Reports Business Highlights and First Quarter 2022 Financial Results
Agios Reports Fourth Quarter and Full Year 2021 Financial Results Read more about Agios Reports Fourth Quarter and Full Year 2021 Financial Results
